Health X Platform last traded at ₹283.50 (2026-10-13). Over the past month the stock moved -7.7%, three months the stock moved -9.5%, year the stock moved -9.1%. Its closing range over 52 weeks is ₹269.00 – ₹327.50, with the latest close 13.4% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services[1]
Business Overview:[1][2][3] SSVL, a Core Investment Company (CIC), operates through multiple subsidiaries and offers a digital platform for pharmacy, wellness, and diagnostics, serving both B2B and B2C segments with person-centric healthcare solutions.
In the latest quarter (Jun 2026), Health X Platform reported sales of ₹446.85 crore (+49.7%) and net profit of ₹1.99 crore (-92.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 446.85 | -8.38 | -1.88 | 1.99 | 0.80 |
| Mar 2026 | 373.78 | -25.19 | -6.74 | -12.97 | -3.51 |
| Dec 2025 | 345.74 | -10.36 | -3.00 | 0.37 | 0.36 |
| Sep 2025 | 301.32 | -22.61 | -7.50 | -15.44 | -3.99 |
| Jun 2025 | 298.43 | 6.06 | 2.03 | 26.59 | 7.52 |
| Mar 2025 | 285.84 | -25.20 | -8.82 | 17.57 | 4.30 |
| Dec 2024 | 281.29 | -23.70 | -8.43 | -37.80 | -8.47 |
| Sep 2024 | 273.53 | -4.72 | -1.73 | -154.78 | -34.39 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -23.7% | -24.9% | -6.8% | +10.4% | +10.2% | +22.9% | +30.8% | +49.7% |
| Operating profit growth | -240.1% | -791.0% | – | – | – | – | – | -238.3% |
| Net profit growth | – | – | -18.6% | -35.1% | – | – | -173.8% | -92.5% |
| EPS growth | – | – | -16.8% | -23.2% | – | – | -181.6% | -89.4% |
| OPM % | -1.7% | -8.4% | -8.8% | 2.0% | -7.5% | -3.0% | -6.7% | -1.9% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Health X Platform reported sales of ₹1,319.00 crore (+18.7%) and net profit of ₹-1.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 1,319 | -52.00 | -4.00 | -1.00 | 0.37 |
| Mar 2025 | 1,111 | -56.00 | -5.00 | -134.00 | -28.66 |
| Mar 2024 | 1,432 | -24.00 | -2.00 | 6.00 | 2.79 |
| Mar 2023 | 1,060 | -107.00 | -10.00 | -99.00 | -22.70 |
| Mar 2022 | 1,798 | 1,114 | 62.00 | 865.00 | 197.05 |
| Mar 2021 | 551.00 | -10.00 | -2.00 | -17.00 | -3.27 |
| Mar 2020 | 388.00 | -52.00 | -13.00 | -52.00 | -12.19 |
| Mar 2019 | 222.00 | -33.00 | -15.00 | -43.00 | -11.81 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +37.0% | +74.8% | +42.0% | +226.3% | -41.0% | +35.1% | -22.4% | +18.7% |
| Operating profit growth | – | – | – | – | -109.6% | – | – | – |
| Net profit growth | – | – | – | – | -111.4% | – | -2333.3% | – |
| EPS growth | – | – | – | – | -111.5% | – | -1127.2% | – |
| OPM % | -15.0% | -13.0% | -2.0% | 62.0% | -10.0% | -2.0% | -5.0% | -4.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Health X Platform.
Get Free AI Stock Analysis FREE →No recent news available for Health X Platform.
Health X Platform shares were last quoted at ₹283.50 (-2.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Health X Platform has a price-to-earnings (P/E) ratio of -671.16 and a price-to-book (P/B) ratio of 1.43. The industry P/E is 39.42.
The 52-week high of Health X Platform is ₹375.00 and the 52-week low is ₹252.50.
The market capitalisation of Health X Platform is about ₹918.05 crore.
In the latest quarter (Jun 2026), Health X Platform reported sales of ₹446.85 crore (+49.7%) and net profit of ₹1.99 crore (-92.5%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Health X Platform has a 3-year ROE of 2.00%, 3-year profit growth of 27.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 74.07% of Health X Platform.
Health X Platform belongs to the Finance - NBFC sector.